A Multi-Center, Observational Registry of Subjects With Secondary Hyperparathyroidism (HPT) and Chronic Kidney Disease (CKD)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00189501

Enrollment

1000

Registered

2005-09-19

Start date

2004-12-31

Completion date

Unknown

Last updated

2007-12-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nephrology

Keywords

Chronic Kidney Disease, CKD,, Secondary Hyperparathyroidism, HPT

Brief summary

Objectives include description of current practices; assessment over time of K/DOQI goals, clinical outcomes, health resource utilization(HRU) and patient reported outcomes (PRO) and the impact of Sensipar® on these parameters

Interventions

DRUGSensipar®

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* 3 month history of Stage 4 or Stage 5 CKD * A PTH value within 3 months of enrollment * If relevant, completion of Sensipar® study prior to enrolling in Registry

Exclusion criteria

* Females who are pregnant or breast feeding

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026